Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2029 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Vical Receives $2.5m Payment As Fund From AnGes

Vical has received $2.5m installment payment from AnGes for the company’s ongoing Allovectin-7 phase 3 metastatic melanoma trial. Reportedly, through a series of cash payments and equity investments

NIH Awards Grant To Vaxart

Vaxart has been awarded a $2.8m phase II Small Business Innovation Research grant from the National Institute of Allergy and Infectious Disease (NIH) to support development of its

DCGI To Issue WHO Compliance Certificates In India

Word Health Organisation has authorised DCGI to issue Pharmaceutical Product (Copp) and good manufacturing practice (GMP) certificates, starting October 1, reported TopNews. The step is expected to streamline

Ipsen, Debiopharm Sign License Agreement

Ipsen and Debiopharm has signed an agreement under which Debiopharm is granted an exclusive worldwide license to develop and commercialise Ipsen’s first-in-class inhibitor of the CDC25 phosphatase enzyme

Pfizer To Launch Drugs In India

Pfizer on Friday announced that it has plans to launch two or three generic drugs in India by December, reported Indiainfoline. It is an attempt to boost sales

Chugai To Increase Supply Of Tamiflu In Japan

Chugai Pharmaceutical has announced to increase the supply of the anti-influenza drug Tamiflu Capsule 75 and Tamiflu Dry Syrup 3% (oseltamivir phosphate) imported from F Hoffmann-La Roche for

Aurobindo Obtains Two Swissmedic Approval

Aurobindo Pharma (Aurobindo) has received two approvals from Swissmedic, Government of Switzerland for the license of Amlodipine APL 5mg and 10mg tablets and Metformin APL 500mg, 850mg and